Filing Details
- Accession Number:
- 0001628280-19-014367
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-20 17:56:10
- Reporting Period:
- 2019-11-18
- Accepted Time:
- 2019-11-20 17:56:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576280 | Guardant Health Inc. | GH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206964 | A Derek Bertocci | 505 Penobscot Drive Redwood City CA 94063 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-18 | 14,722 | $3.63 | 99,684 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-18 | 10,759 | $8.80 | 110,443 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-18 | 12,545 | $79.25 | 97,898 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-18 | 12,936 | $79.90 | 84,962 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | STOCK OPTION (RIGHT TO BUY) | Disposition | 2019-11-18 | 14,722 | $0.00 | 14,722 | $3.63 |
| Common Stock | STOCK OPTION (RIGHT TO BUY) | Disposition | 2019-11-18 | 10,759 | $0.00 | 10,759 | $8.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,742 | 2026-07-26 | No | 4 | M | Direct | |
| 26,131 | 2028-08-21 | No | 4 | M | Direct |
Footnotes
- These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Some of the shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $3.63 or $8.80 per share.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.66 to $79.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.68 to $80.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The stock option vests and becomes exercisable as to 25% of the options on July 18, 2017, thereafter vests in equal monthly installments over 36 months.
- The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on August 22, 2018.
Billionaire Hedge Funds
